SE0402635D0 - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- SE0402635D0 SE0402635D0 SE0402635A SE0402635A SE0402635D0 SE 0402635 D0 SE0402635 D0 SE 0402635D0 SE 0402635 A SE0402635 A SE 0402635A SE 0402635 A SE0402635 A SE 0402635A SE 0402635 D0 SE0402635 D0 SE 0402635D0
- Authority
- SE
- Sweden
- Prior art keywords
- chemical compounds
- compositions
- preparing
- processes
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0402635A SE0402635D0 (sv) | 2004-10-29 | 2004-10-29 | Chemical compounds |
AU2005300148A AU2005300148A1 (en) | 2004-10-29 | 2005-10-26 | Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
PCT/SE2005/001608 WO2006046914A1 (en) | 2004-10-29 | 2005-10-26 | Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
CA002584409A CA2584409A1 (en) | 2004-10-29 | 2005-10-26 | Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
CNA2005800375054A CN101052627A (zh) | 2004-10-29 | 2005-10-26 | 作为糖皮质激素受体调节剂用于治疗炎性疾病的新磺酰胺衍生物 |
RU2007115548/04A RU2007115548A (ru) | 2004-10-29 | 2005-10-26 | Новые сульфонамидные производные в качестве модуляторов глюкокортикоидного рецептора для лечения воспалительных заболеваний |
RSP-2007/0077A RS20070077A (en) | 2004-10-29 | 2005-10-26 | Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflamatory diseases |
MX2007004861A MX2007004861A (es) | 2004-10-29 | 2005-10-26 | Derivados de sulfonamida novedosos como moduladores de receptor glucocorticoide para el tratamiento de enfermedades inflamatorias. |
BRPI0517259-4A BRPI0517259A (pt) | 2004-10-29 | 2005-10-26 | novos derivados de sulfonamida como moduladores do receptor de glicocorticóide para o tratamento de doenças inflamatórias |
US11/718,203 US20110130426A1 (en) | 2004-10-29 | 2005-10-26 | Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases |
KR1020077009608A KR20070072550A (ko) | 2004-10-29 | 2005-10-26 | 염증 질환의 치료를 위한 글루코코르티코이드 수용체조절제로서의 신규 술폰아미드 유도체 |
EP05797057A EP1807405A1 (en) | 2004-10-29 | 2005-10-26 | Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
GT200500306A GT200500306A (es) | 2004-10-29 | 2005-10-27 | Compuestos quimicos |
ARP050104506A AR051471A1 (es) | 2004-10-29 | 2005-10-27 | Derivados de sulfonamida como moduladores del receptor de glugocorticoides |
PA20058651101A PA8651101A1 (es) | 2004-10-29 | 2005-10-28 | Compuestos quimicos |
UY29181A UY29181A1 (es) | 2004-10-29 | 2005-10-28 | Derivados de bencenosulfonamidas n-sustituidos, composiciones que los contienen, procesos de preparación y aplicaciones |
PE2005001261A PE20060931A1 (es) | 2004-10-29 | 2005-10-28 | Derivados de sulfonamida como moduladores de los receptores de glucocorticoides (gr) |
TW094137740A TW200630352A (en) | 2004-10-29 | 2005-10-28 | Chemical compounds |
EC2007007323A ECSP077323A (es) | 2004-10-29 | 2007-03-14 | Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias |
IL182424A IL182424A0 (en) | 2004-10-29 | 2007-04-10 | Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
ZA200703389A ZA200703389B (en) | 2004-10-29 | 2007-04-25 | Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0402635A SE0402635D0 (sv) | 2004-10-29 | 2004-10-29 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0402635D0 true SE0402635D0 (sv) | 2004-10-29 |
Family
ID=33448752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0402635A SE0402635D0 (sv) | 2004-10-29 | 2004-10-29 | Chemical compounds |
Country Status (21)
Country | Link |
---|---|
US (1) | US20110130426A1 (sv) |
EP (1) | EP1807405A1 (sv) |
KR (1) | KR20070072550A (sv) |
CN (1) | CN101052627A (sv) |
AR (1) | AR051471A1 (sv) |
AU (1) | AU2005300148A1 (sv) |
BR (1) | BRPI0517259A (sv) |
CA (1) | CA2584409A1 (sv) |
EC (1) | ECSP077323A (sv) |
GT (1) | GT200500306A (sv) |
IL (1) | IL182424A0 (sv) |
MX (1) | MX2007004861A (sv) |
PA (1) | PA8651101A1 (sv) |
PE (1) | PE20060931A1 (sv) |
RS (1) | RS20070077A (sv) |
RU (1) | RU2007115548A (sv) |
SE (1) | SE0402635D0 (sv) |
TW (1) | TW200630352A (sv) |
UY (1) | UY29181A1 (sv) |
WO (1) | WO2006046914A1 (sv) |
ZA (1) | ZA200703389B (sv) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200800150A (en) | 2005-12-21 | 2008-01-01 | Organon Nv | Compounds with medicinal effects due to interaction with the glucocorticoid receptor |
TW200829578A (en) | 2006-11-23 | 2008-07-16 | Astrazeneca Ab | Chemical compounds 537 |
JO2754B1 (en) | 2006-12-21 | 2014-03-15 | استرازينكا ايه بي | Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders |
EP2428504B1 (en) * | 2008-04-14 | 2017-05-17 | The Board of Regents of the University of Texas System | Small molecule inhibitors of the pleckstrin homology domain and method for using same |
TWI445705B (zh) | 2008-05-20 | 2014-07-21 | Astrazeneca Ab | 經苯基及苯并二基取代之吲唑衍生物 |
AR072297A1 (es) | 2008-06-27 | 2010-08-18 | Novartis Ag | Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona. |
PL3263564T3 (pl) | 2012-02-29 | 2020-11-16 | Chemocentryx, Inc. | 1h-pirazol-1-ilo benzenosulfonamidy aza-arylowe jako antagoniści ccr(9) |
MX2015007608A (es) | 2012-12-14 | 2016-04-13 | Phusis Therapeutics Inc | Metodos y composiciones para inhibir cnksr1. |
KR20240033093A (ko) | 2014-10-06 | 2024-03-12 | 케모센트릭스, 인크. | C-c 케모카인 수용체 타입 9 (ccr9)의 억제제 및 항-알파4베타7 인테그린 차단 항체의 조합 요법 |
US10227317B2 (en) | 2015-02-25 | 2019-03-12 | Lupin Limited | Process for the preparation of vortioxetine |
WO2016172191A1 (en) | 2015-04-20 | 2016-10-27 | Phusis Therapeutics, Inc. | Compounds, compositions and methods for inhibiting cnksr1 |
UA127357C2 (uk) | 2018-04-18 | 2023-07-26 | Констеллатіон Фармацеутікалс, Інк. | Модулятори метилмодифікуючих ферментів, композиції та їх використання |
US11919912B2 (en) | 2018-05-21 | 2024-03-05 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
US10792360B1 (en) | 2019-11-21 | 2020-10-06 | Chemocentryx, Inc. | Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US444347A (en) * | 1891-01-06 | James | ||
US3992441A (en) * | 1972-12-26 | 1976-11-16 | Pfizer Inc. | Sulfamylbenzoic acids |
DE3535167A1 (de) * | 1985-10-02 | 1987-04-09 | Boehringer Mannheim Gmbh | Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel |
DE3632329A1 (de) * | 1986-09-24 | 1988-03-31 | Bayer Ag | Substituierte phenylsulfonamide |
GB9504854D0 (en) * | 1994-03-31 | 1995-04-26 | Zeneca Ltd | Nitrogen derivatives |
US5545669A (en) * | 1994-06-02 | 1996-08-13 | Adams; Jerry L. | Anti-inflammatory compounds |
AU5772296A (en) * | 1995-05-19 | 1996-11-29 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
TW523506B (en) * | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
JP4253126B2 (ja) * | 1998-01-29 | 2009-04-08 | アムジェン インコーポレイテッド | Ppar−ガンマ調節剤 |
US6569885B1 (en) * | 1999-12-23 | 2003-05-27 | Icos Corporation | Cyclic AMP-specific phosphodiesterase inhibitors |
EP1432693A2 (en) * | 2001-10-01 | 2004-06-30 | Taisho Pharmaceutical Co. Ltd. | Mch receptor antagonists |
AU2003248549B2 (en) * | 2002-05-24 | 2010-04-08 | Millennium Pharmaceuticals, Inc. | CCR9 inhibitors and methods of use thereof |
JP5008025B2 (ja) * | 2003-02-20 | 2012-08-22 | エンサイシブ・ファーマシューティカルズ・インコーポレイテッド | フェニレンジアミンウロテンシン−ii受容体拮抗薬およびccr−9拮抗薬 |
US7393873B2 (en) * | 2003-07-02 | 2008-07-01 | Merck & Co., Inc. | Arylsulfonamide derivatives |
US20050250820A1 (en) * | 2004-03-08 | 2005-11-10 | Amgen Inc. | Therapeutic modulation of PPARgamma activity |
-
2004
- 2004-10-29 SE SE0402635A patent/SE0402635D0/sv unknown
-
2005
- 2005-10-26 AU AU2005300148A patent/AU2005300148A1/en not_active Abandoned
- 2005-10-26 US US11/718,203 patent/US20110130426A1/en not_active Abandoned
- 2005-10-26 WO PCT/SE2005/001608 patent/WO2006046914A1/en active Application Filing
- 2005-10-26 MX MX2007004861A patent/MX2007004861A/es not_active Application Discontinuation
- 2005-10-26 KR KR1020077009608A patent/KR20070072550A/ko not_active Application Discontinuation
- 2005-10-26 BR BRPI0517259-4A patent/BRPI0517259A/pt not_active Application Discontinuation
- 2005-10-26 RU RU2007115548/04A patent/RU2007115548A/ru unknown
- 2005-10-26 EP EP05797057A patent/EP1807405A1/en not_active Withdrawn
- 2005-10-26 CA CA002584409A patent/CA2584409A1/en not_active Abandoned
- 2005-10-26 RS RSP-2007/0077A patent/RS20070077A/sr unknown
- 2005-10-26 CN CNA2005800375054A patent/CN101052627A/zh active Pending
- 2005-10-27 GT GT200500306A patent/GT200500306A/es unknown
- 2005-10-27 AR ARP050104506A patent/AR051471A1/es not_active Application Discontinuation
- 2005-10-28 TW TW094137740A patent/TW200630352A/zh unknown
- 2005-10-28 UY UY29181A patent/UY29181A1/es not_active Application Discontinuation
- 2005-10-28 PA PA20058651101A patent/PA8651101A1/es unknown
- 2005-10-28 PE PE2005001261A patent/PE20060931A1/es not_active Application Discontinuation
-
2007
- 2007-03-14 EC EC2007007323A patent/ECSP077323A/es unknown
- 2007-04-10 IL IL182424A patent/IL182424A0/en unknown
- 2007-04-25 ZA ZA200703389A patent/ZA200703389B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU2005300148A1 (en) | 2006-05-04 |
IL182424A0 (en) | 2007-07-24 |
ECSP077323A (es) | 2007-04-26 |
US20110130426A1 (en) | 2011-06-02 |
CN101052627A (zh) | 2007-10-10 |
BRPI0517259A (pt) | 2008-10-07 |
MX2007004861A (es) | 2007-05-09 |
RS20070077A (en) | 2008-09-29 |
PA8651101A1 (es) | 2006-06-02 |
TW200630352A (en) | 2006-09-01 |
RU2007115548A (ru) | 2008-12-10 |
GT200500306A (es) | 2006-06-06 |
EP1807405A1 (en) | 2007-07-18 |
PE20060931A1 (es) | 2006-10-13 |
AR051471A1 (es) | 2007-01-17 |
UY29181A1 (es) | 2006-05-31 |
WO2006046914A1 (en) | 2006-05-04 |
KR20070072550A (ko) | 2007-07-04 |
ZA200703389B (en) | 2009-12-30 |
CA2584409A1 (en) | 2006-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200630326A (en) | Chemical compounds | |
TW200630352A (en) | Chemical compounds | |
UY29875A1 (es) | Compuestos quimicos | |
TW200610761A (en) | Chemical compounds | |
MX2009011997A (es) | Derivados de pirrolopirimidin-7-ona y su uso como farmaceuticos. | |
UY30736A1 (es) | Compuestos quimicos 537 | |
SE0401345D0 (sv) | Therapeutic compounds: Pyridine as scaffold | |
SE0402762D0 (sv) | Indazole sulphonamide derivatives | |
SE0401762D0 (sv) | Novel compounds | |
MX2010001574A (es) | Ligandos del receptor cannabinoide. | |
SE0401342D0 (sv) | Therapeutic compounds | |
SE0302573D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
TW200610759A (en) | Chemical compounds | |
SE0301701D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
TW200626581A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
SE0301320D0 (sv) | Positive modulators of nicotinic acetylcholine receptors | |
SE0103819D0 (sv) | Chemical compounds | |
UA83832C2 (ru) | Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и их применение | |
SE0302570D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0401763D0 (sv) | Compounds | |
SE0301369D0 (sv) | Chemical compounds | |
SE0302572D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0401656D0 (sv) | Chemical compounds | |
SE0203820D0 (sv) | chemical compounds | |
SE0402636D0 (sv) | Chemical compounds |